{"sourcedb":"DevicePMAs@therightstef","sourceid":"P130024_S009","text":"Approval for Lutonix DCB is indicated for percutaneous transluminal angioplasty, after appropriate vessel preparation, of de novo, restenotic, or in-stent restenotic lesions up to 300 mm in length in native superficial femoral or popliteal arteries with reference vessel diameters of 4-7 mm.","project":"consensus_PMA_Age_Indications"}